Caplight Directory>Companies>OncoDiag-preview>Oncodiag


OncoDiag

OncoDiag

Private
FranceN/Ahttps://www.oncodiag.fr/

Last Round

Follow-on

Feb 5, 2025

Total Funding Raised

$4.2M

Momentum Score

50 /100

Company Overview

OncoDiag is a genomics company that develops non-invasive diagnostic tests for the early detection and monitoring of bladder, colorectal, and prostate cancer.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoDiag Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OncoDiag Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Follow-onFeb 5, 2025
Series AMar 15, 2021
View all Funding Rounds

OncoDiag Investors

Notable investors and investment history

InvestorRounds
Les Business Angels des Grandes ÉcolesSeed
Normandie ParticipationsSeries A
Paris Business AngelsFollow-on, Series A
Les Business Angels des Grandes EcolesFollow-on, Series A
Angels SantéFollow-on, Seed, Series A
Normandie ParticipationsFollow-on, Series A
BpifranceSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors grew 70% MoM, reaching 1.5K.

  • May 4, 2025

    Monthly visitors grew 136% MoM.

View all signals

OncoDiag Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoDiag Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoDiag's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrance
Employee Range7
Year Founded2013
Last FundingFeb 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.